Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.
about
Electrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomicsSerum Glycopatterns as Novel Potential Biomarkers for Diagnosis of Acute-on-Chronic Hepatitis B Liver FailureGlycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors.Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation.Alteration of matrix metalloproteinase-3 O-glycan structure as a biomarker for disease activity of rheumatoid arthritis.Sensitive detection and glycoprofiling of a prostate specific antigen using impedimetric assays.Structural analysis and unique molecular recognition properties of a Bauhinia forficata lectin that inhibits cancer cell growth.Label-free chronopotentiometric glycoprofiling of prostate specific antigen using sialic acid recognizing lectins.Role of lectin microarrays in cancer diagnosis.Can glycoprofiling be helpful in detecting prostate cancer?Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.Separation of monosaccharides hydrolyzed from glycoproteins without the need for derivatization.Sweet characterisation of prostate specific antigen using electrochemical lectin-based immunosensor assay and MALDI TOF/TOF analysis: Focus on sialic acid.Cancer cell death induced by nanomagnetolectin.Large-scale intact glycopeptide identification by Mascot database search.Changes in cellular glycosylation of leukemia cells upon treatment with acridone derivatives yield insight into drug action.Analysis of changes in the glycan composition of serum, cytosol and membrane glycoprotein biomarkers of colorectal cancer using a lectin-based protein microarray
P2860
Q26822552-CC2D76AD-A4FA-4AE0-9122-5C8347B8A7EAQ30358956-925FCC06-7A2D-4F9B-B11C-597A9F0175FCQ30382105-A7E72789-8225-4931-955B-77B441DA8712Q36315969-2178AB90-1E7D-43CE-9402-0FACCB48580BQ36923243-04D1F429-FDD4-4282-A3D2-D8539F91DC97Q36945404-A712FF24-E4B2-4524-A5A6-C8EEC648DFB7Q38289777-5A1A9BBB-67EF-4614-AFC1-1BB3FE7B18A8Q38708626-1751E405-84A2-4C01-9758-5F58F69A543AQ38721715-F06A736A-0EE0-491E-BFF4-ECE4B4EFAC67Q38852467-6917894B-E628-4271-AECD-5A187C8B4A53Q39031683-5A51A04B-D592-48EA-A147-7E52FEEA9DD0Q40996193-516AA3FB-04CC-43E4-93A6-ED7CE5365316Q47139131-6D7E54DA-C0B9-4B9A-812D-3F3BBA0D7219Q47808293-EF1F6217-EFB5-4EFC-A5B3-2540E6E05020Q49296534-0D869F01-45CF-4030-97CB-887219194A33Q51417363-A1F54CE7-AA2D-4118-86BD-26677C3EE50CQ59207014-487784DC-48F6-49CD-91AC-BB2029FAA9D9
P2860
Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.
@en
type
label
Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.
@en
prefLabel
Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.
@en
P2093
P2860
P50
P1476
Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers
@en
P2093
Bakhytzhan O Bekmanov
Chen-Zhong Li
Elmira M Khussainova
Leyla B Djansugurova
William C S Cho
Xueji Zhang
P2860
P304
P356
10.1586/14789450.2014.897611
P577
2014-03-10T00:00:00Z